Science and business professionals from across the region will have an opportunity to learn about—and perhaps even commercialize—cutting-edge technologies being used to address some of the most urgent and intractable problems in the biomedical sciences at an upcoming event held at the Frederick National Laboratory for Cancer Research.

The Frederick National Laboratory for Cancer Research recently formed a partnership with the Pancreatic Cancer Action Network (PanCAN) to award a one-year fellowship to two scientists whose research will help lead to new therapies for pancreatic cancer. The scientists will focus on KRAS, a gene in the RAS family that is mutated in 95 percent of pancreatic cancers, according to the National Cancer Institute.

As the fall and winter seasons progress, you may be attending more scientific conferences, where you may find a number of opportunities for research collaborations. To assist your lab in reaching its research goals through collaborations, the staff of the National Cancer Institute Technology Transfer Center can guide you through a tool box of agreements you may need for protecting your intellectual property and effectively managing your collaboration.

Advancing scientific discovery is increasingly dependent on diverse and innovative partnerships, and the Cooperative Research and Development Agreement (CRADA) is an essential tool for establishing partnerships. CRADAs allow a federal laboratory to enter into collaborative research and development projects with outside parties (commercial or nonprofit).

The three-story, 330,000-square-foot Advanced Technology Research Facility has nearly 40,000 square feet designated as partnership space (shown in blue) for co-location of collaborators from industry, academia, nonprofit sectors, and other government agencies. The partnership space, combined with multiple conference rooms and meeting areas, encourages both internal and external collaborations.